Scientific notes

Organ-on-a-Chip: A New Paradigm for Drug Development

Introduction

Organ-on-a-Chip is a potential, multidisciplinary method for in-vitro modeling of disease, drug screening, and precision medicine that simulates in-vitro physiology and pathology.
Organ-on-a-chip technology may be integrated organically into the drug development pipeline for preclinical screening, testing, and translating novel medicines from early drug discovery to bridging the gap between animal and human subject research.

In the future, it will be unprecedented to promote its biomedical applications through further development of customized organ-on-a-chip and ongoing integration of novel engineering tools (i.e. automation handling, 3D printing, in situ multi-Sensor systems) and biological concepts (e.g. patient-induced pluripotent stem cells and organoids).

How to culture vascularized & immunocompetent 3D models in a standard Multiwell

Abstract

The authors state that “The pharmaceutical industry has been desperately searching for efficient drug discovery methods. Organ-on-a-Chip, a cutting-edge technology that can emulate the physiological environment and functionality of human organs on a chip for disease modeling and drug testing, shows great potential for revolutionizing the drug development pipeline.

However, successful translation of this novel engineering platform into routine pharmacological and medical scenarios remains to be realized. In this review, we discuss how the Organ-on-a-Chip technology can have critical roles in different preclinical stages of drug development and highlight the current challenges in translation and commercialization of this technology for the pharmacological and medical end-users.

Moreover, this review sheds light on the future developmental trends and need for a next-generation Organ-on-a-Chip platform to bridge the gap between animal studies and clinical trials for the pharmaceutical industry.”.

References

Ma C, Peng Y, Li H, Chen W. Organ-on-a-Chip: A New Paradigm for Drug Development. Trends Pharmacol Sci. 2021 Feb;42(2):119-133. doi: 10.1016/j.tips.2020.11.009. Epub 2020 Dec 16. PMID: 33341248; PMCID: PMC7990030.

Related Posts

Tumor_targeting
3D cell culture and anticancer drug testing...
Efficacity and toxicity of candidate anticancer drugs on 3D cell culture model has been much lower than on 2D cell culture models over the p...
Read more
3d-cell-culture-intestinal-anatomy-histology
Intestinal Biopsies Beyond Histological Diagnosis: Ex-vivo Cultur...
Intestine: Overview, Histology and Pathology The intestine is the largest part of the alimentary canal, which is part of the gastrointestina...
Read more
Imaging of mitochondria positioning on microtubule using fast tem...
Abstract of mmb1p Binds Mitochondria to Dynamic Microtubules  Mitochondria form a dynamic tubular network within the cell. Proper mitochond...
Read more

get in touch

Get the best insights about Cherry Biotech by Email Let’s stay in touch!
As part of our commercial prospecting, we may need to process your personal data. For more information, please consult our Privacy Policy